Rapid Tranquillisation: An AGREEable Ground?


Objective: Evidence base for rapid tranquillisation is an under researched area. Guidelines on rapid tranquilisation from English speaking countries were appraised using AGREE (Appraisal of Guidelines Research and Evaluation) and differences in their recommendations were analysed. Methods: Four independent psychiatrists appraised the guidelines using the AGREE tool. AGREE is a validated instrument used to assess the quality of guideline and recommendations using six domains of which each domain captures a specific aspect of the guideline development. The content was analysed manually. Results: Seven guidelines from five English speaking countries met the inclusion criteria. All the guidelines scored well on the domain of “scope and purpose”. NICE guidelines from the UK consistently scored well on all domains with the maximum possible score of 100 on the “applicability” domain. APA from the USA did well on the domain of “editorial independence”. AGREE could only examine the guideline development process and not the content. The guidelines differed in their recommendations of choice of drug for rapid tranquillisation. Discussion: All guidelines scored reasonably well on AGREE. National Institute of Clinical Excellence (NICE) has used robust strategies in developing the guidelines. Guidelines failed to achieve consensus in recommendations despite using a common pool of evidence. Haloperidol-promethazine combination is not recommended by any with the exception of NICE. This suggests data is selectively interpreted depending on locally prevalent customs.

Share and Cite:

Nadkarni, P. , Jayaram, M. , Nadkarni, S. , Rattehalli, R. and Adams, C. (2014) Rapid Tranquillisation: An AGREEable Ground?. Open Journal of Psychiatry, 4, 269-274. doi: 10.4236/ojpsych.2014.43033.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Atakan, Z.D. (1997) ABC of Mental Health. Mental Health Emergencies. BMJ, 314, 1740-1742. http://dx.doi.org/10.1136/bmj.314.7096.1740
[2] Macpherson, R., Dix, R. and Morgan, S. (2005) A Growing Evidence Base for Management Guidelines. Advances in Psychiatric Treatment, 11, 404-415. http://dx.doi.org/10.1192/apt.11.6.404
[3] Pereira, S., Paton, C., Walkert, L., et al. (2005) Treatment of Acute Behavioural Disturbance: A UK National Survey of Rapid Tranquillisation. Journal of Psychiatric Intensive Care, 1, 84-88.
[4] Gaebel, W., Weinmann, S., Sartorius, N., Rutz, W. and McIntyre, J.S. (2005) Schizophrenia Practice Guidelines: International Survey and Comparison. The British Journal of Psychiatry, 187, 248-255. http://dx.doi.org/10.1192/bjp.187.3.248
[5] The AGREE Collaboration. Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument (Accessed 21 March 2008). http://www.agreecollaboration.org
[6] National Institute for Clinical Excellence: Clinical Guideline 25. Violence: The Short-Term Management of Disturbed/Violent Behaviour in In-Patient Psychiatric Settings and Emergency Departments. London: NICE 2005.
[7] Expert Consensus Panel for Behavioural Emergencies: Expert Consensus Guideline Series. Treatment of Behavioural Emergencies. Journal of Psychiatric Practice, 2005, 11, 5-108.
[8] Macpherson, R., Dix, R. and Morgan, S. (2005) A Growing Evidence Base for Management Guidelines. Advances in Psychiatric Treatment, 11, 404-415. http://dx.doi.org/10.1192/apt.11.6.404
[9] Huf, G., Coutinho, E., Fagundes Jr., H., Oliveira, E., Lopez, J., Gewandszajder, M., Carvalho, A., Keusen, A. and Adams, C. (2002) Current Practices in Managing Acutely Disturbed Patients at Three Hospitals in Rio de Janeiro-Brazil: A Prevalence Study. BMC Psychiatry, 2, 4.
[10] TREC, Collaborative, Group (2003) Rapid Tranquillisation for Agitated Patients in Emergency Psychiatric Rooms: A Randomised Trial of Midazolam versus Haloperidol plus Promethazine. BMJ, 327, 708-713. http://dx.doi.org/10.1136/bmj.327.7417.708
[11] Gibson, R., Fenton, M., Coutinho, E. and Campbell, C. (2005) Zuclopenthixol Acetate in the Treatment of Acute Schizophrenia and Similar Serious Mental Illnesses. Cochrane Database of Systematic Reviews, Article No: CD000525. http://dx.doi.org/10.1002/14651858.CD000525.pub2
[12] McGorry, P. (2004) Royal Australian and New Zealand College of Psychiatrists: Clinical Practice Guidelines for the Treatment of Schizophrenia and Related Disorders. Australian and New Zealand Journal of Psychiatry, 39, 1-30
[13] Canadian Psychiatric Association (2005) Clinical Practice Guidelines: Treatment of Schizophrenia. The Canadian Journal of Psychiatry, 50, 1-56.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.